Merit Medical Systems (MMSI) last issued guidance on February 24, 2026 for fiscal year 2026. The company guided earnings per share in the range of $4.01 - $4.15, compared to a consensus EPS estimate of $3.73. Merit Medical Systems also guided revenue in the range of $1.61B - $1.63B for the period.
Compared to prior guidance, Merit Medical Systems raised its revenue forecast from a prior range of $389.00M - $395.00M.
Merit Medical Systems has issued 24 guidance updates between April 27, 2022 and February 24, 2026. During this period, the company raised its outlook 11 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
Review all historical guidance issued by Merit Medical Systems, including EPS and revenue forecasts across quarterly and annual periods.
The most recent guidance for Merit Medical Systems (MMSI) was reported on February 24, 2026 for the fiscal year 2026. The company provided earnings per share guidance in the range of $4.01 to $4.15, compared to the estimated EPS of $3.73. Additionally, Merit Medical Systems forecasted revenue between $1.61B and $1.63B for the period.
Merit Medical Systems (MMSI) guided EPS in the range of $4.01 to $4.15 for the fiscal year 2026. The consensus analyst EPS estimate is $3.73.
Merit Medical Systems (MMSI) guided revenue in the range of $1.61B to $1.63B for the fiscal year 2026.
Merit Medical Systems (MMSI) raised its revenue guidance from a prior range of $389.00M - $395.00M to $1.61B - $1.63B for the fiscal year 2026.
Merit Medical Systems (MMSI) last issued guidance on February 24, 2026 for the fiscal year 2026.